All In MedTech

FDA Clearance Tracker · P030011-S007

SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 28, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 28, 2010

Approved

Time to decision

103 days

Received Jan 15, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030011-S007
Device name
SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART
Applicant location
Tucson, AZ
Received
Jan 15, 2010
Decided
Apr 28, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P030011

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code LOZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE TRADE NAME CHANGE OF THE SUBJECT DEVICE. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART AND IS INDICATED FOR USE IN TRANSPLANT-ELIGIBLE CANDIDATES IN IMMINENT DANGER OF DEATH FROM IRREVERSIBLE BIVENTRICULAR FAILURE.

Source documents

Other decisions for Syncardia Systems, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.